Article info

Download PDFPDF

MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero

Authors

  • Essi Heinonen Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Stockholm Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Barbara Szymanska-von Schultz Division of Obstetrics and Gynaecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden Department of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Viktor Kaldo Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, Stockholm, Växjö, Sweden PubMed articlesGoogle scholar articles
  • Josefine Nasiell Division of Obstetrics and Gynaecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden Department of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Ewa Andersson Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Mikaela Bergmark Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Margareta Blomdahl-Wetterholm Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Lisa Forsberg Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Stockholm Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Erik Forsell Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Anna Forsgren Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Stockholm PubMed articlesGoogle scholar articles
  • Sandra Frööjd Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Amy Goldman Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Eva-Mari Nordenadler Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Myrto Sklivanioti Psychiatry South West, Stockholm Health Care Region, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Mats Blennow Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Stockholm Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Katarina Wide Division of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Huddinge, Stockholm Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Lars L Gustafsson Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Mrs. Essi Heinonen; essi.heinonen{at}ki.se
View Full Text

Citation

Heinonen E, Szymanska-von Schultz B, Kaldo V, et al
MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero

Publication history

  • Received March 29, 2018
  • Revised June 12, 2018
  • Accepted June 20, 2018
  • First published August 5, 2018.
Online issue publication 
August 05, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.